“Ozempic (Semaglutide) for the Treatment of Obesity: Advantages and Disadvantages from an Integrative Analysis”. Research, Society and Development, vol. 11, no. 11, Sept. 2022, p. e587111133963 , https://doi.org/10.33448/rsd-v11i11.33963.